265 related articles for article (PubMed ID: 23083868)
1. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
Rink M; Xylinas E; Babjuk M; Hansen J; Pycha A; Comploj E; Lotan Y; Sun M; Karakiewicz PI; Abdennabi J; Fajkovic H; Loidl W; Chun FK; Fisch M; Scherr DS; Shariat SF
J Urol; 2012 Dec; 188(6):2120-7. PubMed ID: 23083868
[TBL] [Abstract][Full Text] [Related]
2. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
[TBL] [Abstract][Full Text] [Related]
3. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.
Serretta V; Altieri V; Morgia G; Di Lallo A; Carrieri G; Allegro R;
Urology; 2013 Feb; 81(2):277-81. PubMed ID: 23374781
[TBL] [Abstract][Full Text] [Related]
5. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
Xylinas E; Kluth LA; Rieken M; Lee RK; Elghouayel M; Ficarra V; Margulis V; Lotan Y; Rouprêt M; Martinez-Salamanca JI; Matsumoto K; Seitz C; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF;
BJU Int; 2014 Jul; 114(1):56-61. PubMed ID: 24053463
[TBL] [Abstract][Full Text] [Related]
6. Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
Li HM; Azhati B; Rexiati M; Wang WG; Li XD; Liu Q; Wang YJ
Int Urol Nephrol; 2017 Jan; 49(1):69-76. PubMed ID: 27766490
[TBL] [Abstract][Full Text] [Related]
7. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
Rink M; Furberg H; Zabor EC; Xylinas E; Babjuk M; Pycha A; Lotan Y; Karakiewicz PI; Novara G; Robinson BD; Montorsi F; Chun FK; Scherr DS; Shariat SF
Eur Urol; 2013 Apr; 63(4):724-32. PubMed ID: 22925575
[TBL] [Abstract][Full Text] [Related]
8. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.
Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS
BJU Int; 2007 Aug; 100(2):281-6; discussion 286. PubMed ID: 17419696
[TBL] [Abstract][Full Text] [Related]
9. Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer.
Simonis K; Shariat SF; Rink M;
Curr Opin Urol; 2014 Sep; 24(5):492-9. PubMed ID: 24887046
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
11. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
Alkhateeb SS; Van Rhijn BW; Finelli A; van der Kwast T; Evans A; Hanna S; Vajpeyi R; Fleshner NE; Jewett MA; Zlotta AR
J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
[TBL] [Abstract][Full Text] [Related]
12. Impact of smoking intensity on outcomes of patients with non muscle invasive bladder cancer treated by BCG immunotherapy.
Ajili F; Kourda N; Karay S; Darouiche A; Chebil M; Boubaker S
Ultrastruct Pathol; 2013 Aug; 37(4):273-7. PubMed ID: 23634794
[TBL] [Abstract][Full Text] [Related]
13. Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder.
Sfakianos JP; Shariat SF; Favaretto RL; Rioja J; Herr HW
BJU Int; 2011 Aug; 108(4):526-30. PubMed ID: 21114611
[TBL] [Abstract][Full Text] [Related]
14. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G
Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111
[TBL] [Abstract][Full Text] [Related]
15. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.
Lammers RJ; Witjes WP; Hendricksen K; Caris CT; Janzing-Pastors MH; Witjes JA
Eur Urol; 2011 Oct; 60(4):713-20. PubMed ID: 21794974
[TBL] [Abstract][Full Text] [Related]
16. Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.
Ogihara K; Kikuchi E; Yuge K; Ito Y; Tanaka N; Matsumoto K; Miyajima A; Asakura H; Oya M
Ann Surg Oncol; 2016 May; 23(5):1752-9. PubMed ID: 26671037
[TBL] [Abstract][Full Text] [Related]
17. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
18. Smoking and survival after radical cystectomy for bladder cancer.
Lee C; Kim KH; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
Urology; 2012 Dec; 80(6):1307-12. PubMed ID: 23044645
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
[TBL] [Abstract][Full Text] [Related]
20. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
